Literature DB >> 12675320

High 123I-IMP retention on SPECT image in primary central nervous system lymphoma.

Jun Shinoda1, Hirohito Yano, Satoru Murase, Shin-ichi Yoshimura, Noboru Sakai, Takahiko Asano.   

Abstract

The purpose of this study is to characterize the time course of N-isopropyl-p-[123I]-iodoamphetamine (123I-IMP) uptake of primary central nervous system lymphomas (PCNSL) comparing with those of other common brain tumors such as malignant gliomas and meningioma. Ten patients with PCNSL, 14 with malignant gliomas and 7 with meningioma underwent 123I-IMP single photon emission computerized tomography (SPECT). Four (40%), 7 (70%) and 9 cases (90%) of PCNSL showed IMP index more than 1 on early (15 min), delayed (6 h) and extra-delayed (24 h) SPECT images, respectively. In contrast with those IMP index was less than 1 on any image of both malignant gliomas and meningioma. The PCNSL cases with IMP index more than 1 could be distinguished from malignant gliomas and meningioma visually. The mean value of IMP index of PCNSL was increased time-dependently and was higher than those of the other two brain tumor groups on SPECT images of any time phases, and statistically different from those of malignant gliomas, however, not from those of meningioma. Interestingly, the retention rates of 123I-IMP from early to extra-delayed image and delayed to extra-delayed image in PCNSL were significantly higher than those of both malignant gliomas and meningioma. The high 123I-IMP retention on SPECT image is regarded as characteristic in PCNSL and the evaluation of this character is suggested to be more useful for diagnosis of this tumor than that of 123I-IMP up-take on a single SPECT image.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12675320     DOI: 10.1023/a:1022583610812

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  12 in total

1.  Iodine-123 IMP uptake in brain metastases from lung cancer.

Authors:  I J Szasz; D Lyster; R T Morrison
Journal:  J Nucl Med       Date:  1985-11       Impact factor: 10.057

2.  [Sequential study of glioblastoma with high uptake of N-isopropyl-p-[123I]iodoamphetamine: a case report].

Authors:  Y Araki; H Yamada
Journal:  Kaku Igaku       Date:  1989-04

3.  A case of primary malignant lymphoma of the brain with high uptake of 123I-IMP.

Authors:  S Ohkawa; A Yamadori; E Mori; M Tabuchi; Y Ohsumi; T Yoshida; Y Yoneda; M Furumoto
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

4.  [A case of multiple sclerosis with abnormal single photon emission computed tomography (SPECT)].

Authors:  I Horiuchi; K Mitsuo
Journal:  Rinsho Shinkeigaku       Date:  1999-04

5.  Decreased accumulation of isopropyl-lodoamphetamine (I-123) in brain tumors.

Authors:  N D LaFrance; H N Wagner; P Whitehouse; E Corley; T Duelfer
Journal:  J Nucl Med       Date:  1981-12       Impact factor: 10.057

6.  Secondary malignant lymphoma of the central nervous system with delayed high uptake on 123I-IMP single-photon emission computerized tomography. Case report.

Authors:  C Kitanaka; T Eguchi; T Kokubo
Journal:  J Neurosurg       Date:  1992-05       Impact factor: 5.115

7.  Increased accumulation of N-isopropyl-(I-123)p-iodoamphetamine in bronchial carcinoid tumor.

Authors:  S Nishizawa; T Higa; Y Kuroda; A Sano; M Murakami; Y Takahashi
Journal:  J Nucl Med       Date:  1990-02       Impact factor: 10.057

8.  Unusual uptake and retention of I-123 IMP in brain tumors.

Authors:  S Nakano; K Kinoshita; S Jinnouchi; H Hoshi; K Watanabe
Journal:  Clin Nucl Med       Date:  1988-10       Impact factor: 7.794

9.  [Diagnostic value of high N-isopropyl-p-[123I] iodoamphetamine (IMP) uptake in brain tumors].

Authors:  T Fukahori; T Tahara; F Mihara; A Kato; H Masumoto; S Kudo; T Tsuji; K Tabuchi
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  1996-01

10.  [Primary intracranial melanoma: a case report].

Authors:  S Takano; M Saito; K Murata; M Ohbu; Y Miyasaka; K Yada; S Kan; H Takagi
Journal:  No Shinkei Geka       Date:  1992-11
View more
  2 in total

Review 1.  Central nervous system lymphoma: characteristic findings on traditional and advanced imaging.

Authors:  I S Haldorsen; A Espeland; E-M Larsson
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-08       Impact factor: 3.825

2.  Usefulness of dual isotope 123I-IMP and 201Tl SPECT for the diagnosis of primary central nervous system lymphoma and glioblastoma.

Authors:  Sho Osawa; Masahiko Tosaka; Keishi Horiguchi; Azusa Tokue; Tetsuya Higuchi; Yoshito Tsushima; Yuhei Yoshimoto
Journal:  Int J Clin Oncol       Date:  2022-05-13       Impact factor: 3.850

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.